|
|
260 East Grand Avenue
South San Francisco, CA 94080 USA
phone:(650) 243-3100
fax:(650) 243-3260
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.kalobios.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Human antibody therapeutics for infectious diseases, autoimmunce disorders, and cancer. |
|
| Management |
| David W. Pritchard, President & Chief Executive Officer; Geoffrey Yarranton, Ph.D., Chief Scientific Officer, Executive Vice President, Research & Development; Tillman Pearce, M.D. - Chief Medical Officer; Dan Shochat, Ph.D., Vice President, Head of Non-clinical Development; Charles J. Democko, Vice President, Regulatory Affairs & Quality; Carol Stratford, Ph.D., J.D., General Counsel; Christopher Bebbington, Ph.D., Vice President, Research; Jeanne Y. Jew, Head of Business Development; Thomas C. Yonker, Head of Project Management |
| |
|
|
| |
|
| Keywords |
| pharmaceuticals, antibodies, infectious disease, autoimmunity, oncology, development, technologies, InfectiousDisease |
|
|
|
| Description |
|
KaloBios Pharmaceuticals (KaloBios) is a biotechnology company that uses its proprietary technologies and proven antibody development team to develop human antibody therapeutics. |
|
| Products / Services |
Products are being developed in three areas: Infectious Disease, autoimmunity, and oncology.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members